Longitudinal contrast-enhanced cone beam breast computed tomography for monitoring treatment response in breast cancer neoadjuvant therapy: a comprehensive assessment
CBBCT enables a comprehensive and efficient tool for monitoring NAT response, showing excellent concordance with MRI, and its multidimensional features are also valuable for predicting pCR.
Authors
- Mengran Zhao
- Aidi Liu (ORCID: https://orcid.org/0000-0002-7869-7245)
- Yueqiang Zhu (ORCID: https://orcid.org/0000-0002-9246-6988)
- Zhaoxiang Ye (ORCID: https://orcid.org/0000-0003-3157-8393)
- Yue Ma
- Yafei Wang (ORCID: https://orcid.org/0000-0003-1251-8117)
- Hong Lü (ORCID: https://orcid.org/0000-0002-1004-1792)
- Yin Lu (ORCID: https://orcid.org/0000-0003-0633-7715)
Institutions
- Radboud University Nijmegen (NL)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Radboud University Medical Center (NL)
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1186/s13058-025-02145-z
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tianjin Medical University
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences